Yeah the announcement specifies the data is from the DREAMHF trial, I was responding to whytees statement.
I'm guessing this data hasn't been presented previously because the measurement of LVEF on all the patients at 12 months took a while to analyse?
Again, it would be nice if they presented the data, as the way they've explained the effect is convoluted, but it's looking promising!
- Forums
- ASX - By Stock
- MSB
- Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE, page-109
-
-
- There are more pages in this discussion • 191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B |
Open | High | Low | Value | Volume |
$1.40 | $1.42 | $1.38 | $4.391M | 3.156M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 48253 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 32922 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 48253 | 1.385 |
5 | 70251 | 1.380 |
15 | 100605 | 1.375 |
8 | 96825 | 1.370 |
3 | 43018 | 1.365 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 32922 | 2 |
1.400 | 77386 | 10 |
1.405 | 24018 | 1 |
1.410 | 116617 | 7 |
1.415 | 58649 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online